AKT1 and head and neck squamous cell carcinoma: In this context, combining PI3K/Akt inhibitors with autophagy inhibitors, such as (hydroxy)chloroquine, has demonstrated superior anti-proliferative effects in HNSCC cell lines compared to PI3K/Akt inhibitors alone [62].